Mamoru Ito
Kyushu University of Health and Welfare
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Mamoru Ito.
Microorganisms | 2018
Yuri Yamamoto; Yumiko Nakanishi; Shinnosuke Murakami; Wanping Aw; Tomoya Tsukimi; Ryoko Nozu; Masami Ueno; Kyoji Hioki; Kenji Nakahigashi; Akiyoshi Hirayama; Masahiro Sugimoto; Tomoyoshi Soga; Mamoru Ito; Masaru Tomita; Shinji Fukuda
Commensal microbiota colonize the surface of our bodies. The inside of the gastrointestinal tract is one such surface that provides a habitat for them. The gastrointestinal tract is a long organ system comprising of various parts, and each part possesses various functions. It has been reported that the composition of intestinal luminal metabolites between the small and large intestine are different; however, comprehensive metabolomic and commensal microbiota profiles specific to each part of the gastrointestinal lumen remain obscure. In this study, by using capillary electrophoresis time-of-flight mass spectrometry (CE-TOFMS)-based metabolome and 16S rRNA gene-based microbiome analyses of specific pathogen-free (SPF) and germ-free (GF) murine gastrointestinal luminal profiles, we observed the different roles of commensal microbiota in each part of the gastrointestinal tract involved in carbohydrate metabolism and nutrient production. We found that the concentrations of most amino acids in the SPF small intestine were higher than those in the GF small intestine. Furthermore, sugar alcohols such as mannitol and sorbitol accumulated only in the GF large intestine, but not in the SPF large intestine. On the other hand, pentoses, such as arabinose and xylose, gradually accumulated from the cecum to the colon only in SPF mice, but were undetected in GF mice. Correlation network analysis between the gastrointestinal microbes and metabolites showed that niacin metabolism might be correlated to Methylobacteriaceae. Collectively, commensal microbiota partially affects the gastrointestinal luminal metabolite composition based on their metabolic dynamics, in cooperation with host digestion and absorption.
Clinical Research and Trials | 2016
Yoshie Kametani; Shin Shimada; Shuhya Mori; Mika Kojima; Shino Ohshima; Kazutaka Kitaura; Takaji Matsutani; Yoshinori Okada; Takashi Yahata; Ryoji Ito; Ikumi Katano; Hiroshi Suemizu; Ryuji Suzuki; Mamoru Ito; Sonoko Habu; Kiyoshi Ando
The developmental process of human antibody (Ab)-secreting B cells in humanized mice is not fully defined. To examine the characteristics of class-switched and Absecreting B cells in humanized mice, we analyzed NOD/Shi-scid, common γc-null mice reconstituted with cord blood-derived hematopoietic stem cells (CB-NOG). Most of the CD138-positive plasmablasts (PBs)/plasma cells (PCs) in the NOG spleen maintained CD5 expression. Moreover, IgG-bearing B cells, including PBs and memory cells, predominantly had a CD21-CD24hiCD5+ phenotype. We examined the expression of CD21, CD24 and CD5 on B cells developed in CB-NOG mice. We observed three types of B cells (CD24high CD21-; T1, CD24low/CD21-; T2, CD24-CD21+; T3) within CB-NOG CD5+ cells, which are similar to transitional B cells. However, the surface marker expression was different from normal transitional B cells. First, CD21 expression was significantly lower than in human peripheral blood and CB-derived mature B cells. Second, the expression of CD5 increased according to the developmental stage. The splenocytes were sorted according to the transitional subsets and examined for IL-10 expression. The CD21-CD24hiCD5+ fraction had the highest IL-10 expression among the CD5+ cells, suggesting the involvement of regulatory B cells. The same fractions were cultured in the presence of CpG and IgM. These stimulated B cells secreted a low level of IgM and IgG Abs to CpG and IgM stimulation in vitro and maintained a CD5+CD21low phenotype. These results demonstrate that IgG-bearing B cells with a CD21-CD24hiCD5+ irregular phenotype are developed in humanized NOG mice and have become the source of antibodies in CB-NOG mice. (250 words). Correspondence to: Yoshie Kametani, Ph.D, Department of Molecular Life Science, Tokai University School of Medicine, 143, Shimokasuya, Isehara, Kanagawa, 259-1193, Japan, Tel: +81-463-93-1121; Fax: +81-463-94-2976; E-mail: [email protected]
International Immunology | 2004
Hidekazu Tamauchi; Masazumi Terashima; Mamoru Ito; Hiroko Maruyama; Nobunao Ikewaki; Matsuhisa Inoue; Xiuhua Gao; Katsuto Hozumi; Sonoko Habu
Archive | 2001
Mamoru Ito; Kimio Kobayashi; Tatsutoshi Nakahata; Koichiro Tsuji; Sonoko Habu; Yoshio Koyanagi; Naoki Yamamoto; Kazuo Sugamura; Kiyoshi Ando; Tatsuji Nomura
Archive | 2016
Mamoru Ito; 伊藤 守; Ikumi Katano; 片野 いくみ
Archive | 2013
Naoki Yamamoto; M. Zahidunnabi; Zhong Yu; Mamoru Ito; Tomohiro Morio; Norio Shimizu; Mitsuo Honda; Satoru Watanabe; Kazuo Terashima; Shinrai Ohta; Shigeo Horibata; Misako Yajima; Yoko Shiozawa
Archive | 2012
Yoshito Ueyama; Yoshio Koyanagi; Kazuo Sugamura; Kohichiro Tsuji; Toshio Heike; Mamoru Ito; Hidefumi Hiramatsu; Kimio Kobayashi; Kazutomo Suzue; Mariko Kawahata; Kyoji Hioki
Archive | 2011
Kiyotaka Kuzushima; Mamoru Ito; Kenzo Takada; Yoshio Koyanagi; Kei Sato; Naoko Misawa; Chuanyi Nie; Yorifumi Satou; Dai Iwakiri; Masao Matsuoka; Rei Takahashi
Archive | 2010
Hiroyuki Miyoshi; Shunichi Kato; Tomomitsu Hotta; Kiyoshi Ando; Takashi Yahata; Shizu Yumino; Yin Seng; Hiroko Miyatake; Tomoko Uno; Yukari Muguruma; Mamoru Ito
Archive | 2010
Taira Maekawa; Mamoru Ito; Hideo Mugishima; Shigetaka Asano; Tatsutoshi Nakahata; Kohichiro Tsuji; Feng Ma; Mika Wada; Hiroshi Yoshino; Yasuhiro Ebihara; Takefumi Ishii; Atsushi Manabe; Ryuhei Tanaka